Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (38 quarters reported)
$255M in Q4 2014 → — now. Hover for any quarter.
As reported for the quarter ended March 31, 2024. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| NT Nothing To Declare | NaN% | New | 0 | — |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended March 31, 2024 · filed May 07, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Boston Scientific Corp | Exited | −39,108 | −$2.26M | — |
| Thermo Fisher Scientific Inc | Exited | −3,794 | −$2.01M | — |
| Axonics Inc | Exited | −24,871 | −$1.55M | — |
| Elevance Health Inc | Exited | −2,627 | −$1.24M | — |
| Icon PLC | Exited | −3,659 | −$1.04M | — |
| LA Laboratory Corp Amer Hldgs | Exited | −3,984 | −$906K | — |
| Encompass Health Corp | Exited | −12,870 | −$859K | — |
| Insulet Corp | Exited | −3,906 | −$848K | — |
| Hologic Inc | Exited | −11,631 | −$831K | — |
| Zimmer Biomet Holdings Inc | Exited | −5,646 | −$687K | — |
Showing the 10 largest of 26 changes.
quarter ended December 31, 2023 · filed February 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Biomarin Pharmaceutical Inc | Trimmed | −174,918 | −$16.9M | 2.6% |
| Bruker Corp | Exited | −111,276 | −$6.93M | — |
| Astrazeneca PLC | Exited | −96,444 | −$6.53M | — |
| Thermo Fisher Scientific Inc | Trimmed | −10,055 | −$5.34M | 11.5% |
| Elevance Health Inc | Trimmed | −10,874 | −$5.13M | 7.1% |
| Avantor Inc | Trimmed | −202,279 | −$4.62M | 3.2% |
| Merck & Co Inc | Exited | −44,384 | −$4.57M | — |
| Argenx Se | Exited | −9,108 | −$4.48M | — |
| Conmed Corp | Exited | −41,984 | −$4.23M | — |
| CC Cooper Cos Inc | Trimmed | −10,545 | −$3.99M | 2.1% |
Showing the 10 largest of 52 changes.
quarter ended September 30, 2023 · filed November 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR S&P 500 ETF Tr | Exited | −6,100 | −$27.1M | — |
| Biomarin Pharmaceutical Inc | Added | +135,966 | +$12M | 14.3% |
| Biomarin Pharmaceutical Inc | Exited | −93,600 | −$8.11M | — |
| LA Laboratory Corp Amer Hldgs | Exited | −32,569 | −$7.86M | — |
| Thermo Fisher Scientific Inc | New | +13,849 | +$7.01M | 6.3% |
| Bruker Corp | Added | +96,030 | +$5.98M | 6.2% |
| The Cigna Group | Trimmed | −19,733 | −$5.65M | 1.6% |
| Agilent Technologies Inc | Exited | −45,762 | −$5.5M | — |
| Avantor Inc | New | +226,877 | +$4.78M | 4.3% |
| Conmed Corp | New | +41,984 | +$4.23M | 3.8% |
Showing the 10 largest of 58 changes.
quarter ended June 30, 2023 · filed August 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR S&P 500 ETF Tr | New | +6,100 | +$27.1M | 23.7% |
| Biomarin Pharmaceutical Inc | Trimmed | −212,014 | −$18.4M | 3.3% |
| BD Becton Dickinson & Co | Trimmed | −63,490 | −$16.8M | 3.1% |
| Elevance Health Inc | Trimmed | −31,690 | −$14.1M | 2.2% |
| Sabra Health Care REIT Inc | Exited | −1,165,923 | −$13.4M | — |
| Biomarin Pharmaceutical Inc | New | +93,600 | +$8.11M | 7.1% |
| TP Teva Pharmaceutical Inds Ltd | Exited | −762,264 | −$6.75M | — |
| Icon PLC | Exited | −26,830 | −$5.73M | — |
| Moderna Inc | Exited | −36,130 | −$5.55M | — |
| Agilent Technologies Inc | New | +45,762 | +$5.5M | 4.8% |
Showing the 10 largest of 65 changes.
quarter ended March 31, 2023 · filed May 15, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| I Invacare Corp | Exited | −56,727,000 | −$48.7M | — |
| BD Becton Dickinson & Co | Added | +70,089 | +$17.3M | 9.8% |
| Biomarin Pharmaceutical Inc | Added | +171,259 | +$16.7M | 12.8% |
| LA Laboratory Corp Amer Hldgs | Trimmed | −45,684 | −$10.5M | 5.3% |
| CD Centene Corp Del | Trimmed | −138,777 | −$8.77M | 1.0% |
| I Invacare Corp | Exited | −10,097,000 | −$8.46M | — |
| Sabra Health Care REIT Inc | Added | +729,399 | +$8.39M | 6.9% |
| Merck & Co Inc | Trimmed | −76,430 | −$8.13M | 2.7% |
| Icon PLC | Trimmed | −32,066 | −$6.85M | 2.9% |
| TP Teva Pharmaceutical Inds Ltd | New | +762,264 | +$6.75M | 3.5% |
Showing the 10 largest of 73 changes.
quarter ended December 31, 2022 · filed February 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Humana Inc | Exited | −32,729 | −$15.9M | — |
| Takeda Pharmaceutical Co Ltd | Exited | −1,102,280 | −$14.3M | — |
| Merck & Co Inc | New | +126,003 | +$14M | 5.7% |
| CD Centene Corp Del | New | +168,363 | +$13.8M | 5.6% |
| QN Qiagen Nv | Trimmed | −263,179 | −$13.1M | 0.8% |
| LE Lilly Eli & Co | Exited | −38,311 | −$12.4M | — |
| BI Baxter Intl Inc | Trimmed | −234,085 | −$11.9M | 0.2% |
| Bristol-myers Squibb Co | Exited | −158,721 | −$11.3M | — |
| OH Omega Healthcare Invs Inc | Exited | −313,762 | −$9.25M | — |
| BD Becton Dickinson & Co | Trimmed | −27,521 | −$7M | 0.7% |
Showing the 10 largest of 76 changes.
quarter ended September 30, 2022 · filed November 14, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Boston Scientific Corp | Exited | −418,165 | −$15.6M | — |
| Takeda Pharmaceutical Co Ltd | New | +1,102,280 | +$14.3M | 4.7% |
| LA Laboratory Corp Amer Hldgs | Added | +62,527 | +$12.8M | 6.5% |
| LE Lilly Eli & Co | New | +38,311 | +$12.4M | 4.0% |
| Bristol-myers Squibb Co | New | +158,721 | +$11.3M | 3.7% |
| Catalent Inc | New | +140,077 | +$10.1M | 3.3% |
| Biomarin Pharmaceutical Inc | Added | +119,399 | +$10.1M | 4.0% |
| SS SPDR S&P 500 ETF Tr | Exited | −25,900 | −$9.77M | — |
| SS SPDR Ser Tr | Exited | −126,000 | −$9.36M | — |
| OH Omega Healthcare Invs Inc | New | +313,762 | +$9.25M | 3.0% |
Showing the 10 largest of 69 changes.
quarter ended June 30, 2022 · filed August 15, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR S&P 500 ETF Tr | Trimmed | −76,000 | −$28.7M | 3.4% |
| QN Qiagen Nv | Added | +342,565 | +$16.2M | 6.6% |
| Astrazeneca PLC | Exited | −240,271 | −$15.9M | — |
| Boston Scientific Corp | New | +418,165 | +$15.6M | 5.5% |
| Bristol-myers Squibb Co | Exited | −194,684 | −$14.2M | — |
| OM Orthofix Med Inc | Exited | −434,803 | −$14.2M | — |
| CD Centene Corp Del | Trimmed | −149,930 | −$12.7M | 2.0% |
| Icon PLC | New | +49,718 | +$10.8M | 3.8% |
| SH Syneos Health Inc | Exited | −123,232 | −$9.98M | — |
| Zoetis Inc | New | +41,100 | +$7.07M | 2.5% |
Showing the 10 largest of 78 changes.
Loading...
